Incyte Genomics (INCY) Misses Q2 Views
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $126.01 +1.29%
Revenue Growth %: +7.3%
Financial Fact:
Basic (in shares): 188.03M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +7.3%
Financial Fact:
Basic (in shares): 188.03M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Incyte Genomics (NASDAQ: INCY) reported Q2 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $19.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Signet shares jump on Q2 profit beat, raised annual guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
